$FTHM
Fathom Holdings Inc.

2021 Q2 Form 10-Q Financial Statement

#000110465921104263 Filed on August 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $84.18M $38.69M $28.84M
YoY Change 117.59% 39.22% 59.07%
Cost Of Revenue $78.41M $36.26M $26.78M
YoY Change 116.25% 39.3% 58.93%
Gross Profit $5.770M $2.430M $2.060M
YoY Change 137.46% 37.29% 60.94%
Gross Profit Margin 6.85% 6.28% 7.14%
Selling, General & Admin $9.766M $2.103M $2.070M
YoY Change 364.37% -24.62% -23.9%
% of Gross Profit 169.24% 86.54% 100.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $744.5K $44.50K $20.00K
YoY Change 1573.07% 344.96% 100.0%
% of Gross Profit 12.9% 1.83% 0.97%
Operating Expenses $88.92M $38.50M $2.070M
YoY Change 130.94% 1280.08% -23.9%
Operating Profit -$4.740M $184.5K -$10.00K
YoY Change -2669.71% -118.08% -99.31%
Interest Expense $1.060K -$30.00K -$30.00K
YoY Change -103.53% 0.0% 0.0%
% of Operating Profit -16.26%
Other Income/Expense, Net $33.66K -$22.66K $0.00
YoY Change -248.54%
Pretax Income -$4.706M $161.8K -$40.00K
YoY Change -3008.79% -115.41% -97.28%
Income Tax -$2.615M $1.000K $0.00
% Of Pretax Income 0.62%
Net Earnings -$2.091M $160.8K -$40.00K
YoY Change -1400.66% -115.46% -97.28%
Net Earnings / Revenue -2.48% 0.42% -0.14%
Basic Earnings Per Share -$0.15 $0.02
Diluted Earnings Per Share -$0.15 $0.02 -$2.930K
COMMON SHARES
Basic Shares Outstanding 14.05M 9.997M
Diluted Shares Outstanding 14.05M 10.03M

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.83M $1.490M $840.0K
YoY Change 761.12% 52.04%
Cash & Equivalents $12.80M $1.490M $840.0K
Short-Term Investments
Other Short-Term Assets $14.13M $400.0K $450.0K
YoY Change 3431.98% 471.43%
Inventory
Prepaid Expenses
Receivables $4.099M $1.980M $1.670M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $31.06M $3.860M $2.970M
YoY Change 704.61% 34.49%
LONG-TERM ASSETS
Property, Plant & Equipment $973.5K $310.0K $370.0K
YoY Change 214.03% 0.0%
Goodwill $20.45M
YoY Change
Intangibles $22.73M
YoY Change
Long-Term Investments
YoY Change
Other Assets $66.04K
YoY Change
Total Long-Term Assets $48.94M $960.0K $930.0K
YoY Change 4998.22% 60.0%
TOTAL ASSETS
Total Short-Term Assets $31.06M $3.860M $2.970M
Total Long-Term Assets $48.94M $960.0K $930.0K
Total Assets $80.00M $4.820M $3.900M
YoY Change 1559.77% 38.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.610M $1.800M $1.310M
YoY Change 156.11% 63.64%
Accrued Expenses $4.496M $1.650M $1.730M
YoY Change 172.5% 70.1%
Deferred Revenue
YoY Change
Short-Term Debt $9.361M $160.0K $30.00K
YoY Change 5750.89% 1500.0%
Long-Term Debt Due $603.4K $20.00K $20.00K
YoY Change 2917.23% 0.0%
Total Short-Term Liabilities $24.50M $4.590M $4.200M
YoY Change 433.82% 56.66%
LONG-TERM LIABILITIES
Long-Term Debt $356.8K $840.0K $530.0K
YoY Change -57.52% 55.56%
Other Long-Term Liabilities $2.869M $150.0K $170.0K
YoY Change 1812.41% 7.14%
Total Long-Term Liabilities $356.8K $990.0K $700.0K
YoY Change -63.96% 45.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.50M $4.590M $4.200M
Total Long-Term Liabilities $356.8K $990.0K $700.0K
Total Liabilities $28.39M $5.580M $4.900M
YoY Change 408.71% 54.14%
SHAREHOLDERS EQUITY
Retained Earnings -$12.98M
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $30.00K
YoY Change
Treasury Stock Shares $5.683K
Shareholders Equity $51.61M -$763.0K -$994.2K
YoY Change
Total Liabilities & Shareholders Equity $80.00M $4.820M $3.900M
YoY Change 1559.77% 38.9%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$2.091M $160.8K -$40.00K
YoY Change -1400.66% -115.46% -97.28%
Depreciation, Depletion And Amortization $744.5K $44.50K $20.00K
YoY Change 1573.07% 344.96% 100.0%
Cash From Operating Activities -$1.713M $350.0K $300.0K
YoY Change -589.31% -975.0% -173.17%
INVESTING ACTIVITIES
Capital Expenditures -$420.2K -$120.0K -$120.0K
YoY Change 250.14% 33.33% 100.0%
Acquisitions
YoY Change
Other Investing Activities -$8.894M
YoY Change
Cash From Investing Activities -$9.314M -$120.0K -$120.0K
YoY Change 7661.75% 33.33% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.476M 420.0K 80.00K
YoY Change 251.42% -85.96%
NET CHANGE
Cash From Operating Activities -1.713M 350.0K 300.0K
Cash From Investing Activities -9.314M -120.0K -120.0K
Cash From Financing Activities 1.476M 420.0K 80.00K
Net Change In Cash -9.551M 650.0K 260.0K
YoY Change -1569.34% -600.0% 160.0%
FREE CASH FLOW
Cash From Operating Activities -$1.713M $350.0K $300.0K
Capital Expenditures -$420.2K -$120.0K -$120.0K
Free Cash Flow -$1.292M $470.0K $420.0K
YoY Change -374.98% 840.0% -220.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001753162
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
us-gaap Net Income Loss
NetIncomeLoss
-5491152
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14744539
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13830351
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
963875
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1699375
CY2021Q2 us-gaap Assets Current
AssetsCurrent
31057950
CY2020Q4 us-gaap Assets Current
AssetsCurrent
32856453
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
973500
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
154599
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4724773
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39412
dei Entity Registrant Name
EntityRegistrantName
FATHOM HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NC
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1518164
dei Entity Address Address Line1
EntityAddressAddressLine1
2000 Regency Parkway Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Cary
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27518
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
455-6040
dei Security12b Title
Security12bTitle
Common Stock, No Par Value
dei Trading Symbol
TradingSymbol
FTHM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14796102
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12830663
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28577396
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3530244
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
984238
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4099379
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1595444
CY2021Q2 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
47475
CY2021Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
9586314
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
437421
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22731288
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
922147
CY2021Q2 us-gaap Goodwill
Goodwill
20447286
CY2020Q4 us-gaap Goodwill
Goodwill
799058
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
66042
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
55301
CY2021Q2 us-gaap Assets
Assets
80000839
CY2020Q4 us-gaap Assets
Assets
35224979
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4610026
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2596206
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4496327
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1063889
CY2021Q2 fthm Escrow Liabilities Current
EscrowLiabilitiesCurrent
3476509
CY2020Q4 fthm Escrow Liabilities Current
EscrowLiabilitiesCurrent
933336
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
18848
CY2021Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
9361428
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
603446
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
256324
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1935925
CY2020Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
36356779
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
123129642
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
63044034
CY2021Q2 fthm Operations And Support Expense
OperationsAndSupportExpense
1683375
CY2021Q2 us-gaap Marketing Expense
MarketingExpense
378437
CY2020Q2 us-gaap Marketing Expense
MarketingExpense
138231
us-gaap Marketing Expense
MarketingExpense
780600
us-gaap Marketing Expense
MarketingExpense
368664
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
140100
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
24502509
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4989855
CY2021Q2 fthm Long Term Debt Excluding Current Maturities And Notes Payable
LongTermDebtExcludingCurrentMaturitiesAndNotesPayable
356841
CY2020Q4 fthm Long Term Debt Excluding Current Maturities And Notes Payable
LongTermDebtExcludingCurrentMaturitiesAndNotesPayable
282950
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2868615
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
301429
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
657777
CY2021Q2 us-gaap Liabilities
Liabilities
28385742
CY2020Q4 us-gaap Liabilities
Liabilities
5574234
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14744539
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13830351
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5683
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5683
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
30000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
30000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64624400
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37168896
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12979303
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7488151
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
51615097
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
29650745
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80000839
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35224979
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84182954
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38688744
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133828443
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67527575
CY2021Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
76729401
fthm Operations And Support Expense
OperationsAndSupportExpense
1751751
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9387237
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1964781
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15508661
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3875582
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
744521
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
44496
us-gaap Depreciation And Amortization
DepreciationAndAmortization
846880
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
24139639
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9996775
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13750775
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9996939
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14048136
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10030025
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13750775
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10016269
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
28293438
us-gaap Depreciation And Amortization
DepreciationAndAmortization
63771
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
88922971
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
38504287
us-gaap Operating Expenses
OperatingExpenses
142017534
us-gaap Operating Expenses
OperatingExpenses
67352051
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14048136
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4740017
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
184457
us-gaap Operating Income Loss
OperatingIncomeLoss
-8189091
us-gaap Operating Income Loss
OperatingIncomeLoss
175524
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
50936
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1064
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-32659
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-248
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-65497
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32594
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37326
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
33658
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22659
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
88014
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-55497
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4706359
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
161798
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8101077
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
120027
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2614925
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2609925
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2091434
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
160798
us-gaap Net Income Loss
NetIncomeLoss
-5491152
us-gaap Net Income Loss
NetIncomeLoss
118027
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
80000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1193454
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2091434
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
51615097
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-994221
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
30000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
100493
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
160798
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-762930
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
29650745
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
25311975
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
80000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2063529
us-gaap Net Income Loss
NetIncomeLoss
-5491152
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
51615097
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1159185
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
83014
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
30000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
225214
us-gaap Net Income Loss
NetIncomeLoss
118027
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-762930
us-gaap Profit Loss
ProfitLoss
-5491152
us-gaap Profit Loss
ProfitLoss
118027
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
846880
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63771
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
50936
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
1332813
us-gaap Share Based Compensation
ShareBasedCompensation
2063529
us-gaap Share Based Compensation
ShareBasedCompensation
225214
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2649925
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
76975
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
99656
us-gaap Other Noncash Expense
OtherNoncashExpense
29150
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1372366
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
899178
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
42338436
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
42444742
us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-42194
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-610716
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
500232
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
981086
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
856099
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1316807
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
684600
fthm Increase Decrease In Escrow Liabilities
IncreaseDecreaseInEscrowLiabilities
2385505
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-101152
fthm Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-274601
fthm Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-51639
fthm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-212129
fthm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-50563
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3242
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-514
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2692578
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
649547
fthm Loan Receivable Forgiven And Used As Purchase Consideration
LoanReceivableForgivenAndUsedAsPurchaseConsideration
165000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12830663
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1490278
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3530244
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16360907
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1490278
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
475605
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9369
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
11013923
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
494567
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
227400
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11984095
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-236769
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7211
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8511
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
80000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
83014
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1403157
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
453581
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1475946
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
498084
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-13200727
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
910862
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29561634
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
579416
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16360907
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1490278
us-gaap Interest Paid Net
InterestPaidNet
4448
us-gaap Interest Paid Net
InterestPaidNet
65560
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2261
fthm Amount Due To Seller
AmountDueToSeller
1816346
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
1839079
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
25311975
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
50600
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12800000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28600000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration:underline;text-decoration-color:#000000;">Certain Significant Risks and Business Uncertainties</i> — The Company is subject to the risks and challenges associated with companies at a similar stage of development. These include dependence on key individuals, successful development and marketing of its offerings, and competition with larger companies with greater financial, technical, and marketing resources. Furthermore, during the period required to achieve substantially higher revenue in order to become consistently profitable, the Company may require additional funds that might not be readily available or might not be on terms that are acceptable to the Company. See “COVID-19 Risks, Impacts and Uncertainties” below, and “Risk Factors” in Part II, Item 1A of this report for further detail regarding the risks the Company faces.</p>
us-gaap Net Income Loss
NetIncomeLoss
100000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;text-decoration:underline;text-decoration-color:#000000;">Use of Estimates</i> — The preparation of the unaudited interim consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to income taxes, deferred tax asset valuation allowances, share-based compensation, goodwill, estimated lives of intangible assets, and intangible asset impairment. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company might differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
us-gaap Number Of Reporting Units
NumberOfReportingUnits
6
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
fthm Notice Period For Cancellation Of Contract
NoticePeriodForCancellationOfContract
P30D
CY2020Q4 us-gaap Goodwill
Goodwill
799058
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
19648228
CY2021Q2 us-gaap Goodwill
Goodwill
20447286
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><i style="font-style:italic;text-decoration:underline;text-decoration-color:#000000;">Reclassifications</i> — Certain amounts in the prior year consolidated financial statements have been reclassified to conform to the current year presentation with no effect on the previously reported net (loss) income or stockholders’ equity. Subsequent to the acquisitions of LiveBy and E4:9, the Company made a change to its segment reporting structure as more fully described in Note 17. This resulted in new line items on the consolidated statement of operations for the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;">Gross commission income is comprised of revenues from the Real Estate Brokerage segment which were previously recorded in revenue </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;">Other service revenue is comprised of revenues not included in the Real Estate Brokerage segment which were previously recorded in revenue</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;">Commission and other agent-related costs is comprised of the direct costs to fulfill the services from the Real Estate Brokerage segment which were previously recorded in cost of revenue</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;">Operations and support are comprised of the direct costs to fulfill the services not included in the Real Estate Brokerage segment which were previously recorded in cost of revenue</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;">Depreciation and amortization represent the depreciation charged on the Company’s fixed assets and intangible assets which were previously recorded in general and administrative expenses.</span></td></tr></table>
CY2021Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2020Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1095317
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
305898
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
121817
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
151299
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
973500
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
154599
CY2021Q2 us-gaap Depreciation
Depreciation
44000
CY2020Q2 us-gaap Depreciation
Depreciation
8000
us-gaap Depreciation
Depreciation
61000
us-gaap Depreciation
Depreciation
16000
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
23681815
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
950526
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22731288
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1087248
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
165101
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
922147
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1769815
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
3488306
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
3388058
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
3279933
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
3021909
CY2021Q2 fthm Finite Lived Intangible Assets Amortization Expense Rolling After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour
7783267
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22731288
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
785000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
48000
CY2021Q2 fthm Deferred Annual Fees Current
DeferredAnnualFeesCurrent
664969
CY2020Q4 fthm Deferred Annual Fees Current
DeferredAnnualFeesCurrent
292696
CY2021Q2 fthm Due To Sellers
DueToSellers
1816346
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2015012
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
771193
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4496327
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1063889
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
960287
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
539274
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
356841
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
282950
CY2016Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0174
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessee Operating Lease Existence Of Residual Value Guarantee
LesseeOperatingLeaseExistenceOfResidualValueGuarantee
false
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
245615
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
34801
us-gaap Operating Lease Cost
OperatingLeaseCost
293289
us-gaap Operating Lease Cost
OperatingLeaseCost
70151
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
95254
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
18044
us-gaap Variable Lease Cost
VariableLeaseCost
123716
us-gaap Variable Lease Cost
VariableLeaseCost
35047
CY2021Q2 us-gaap Lease Cost
LeaseCost
340869
CY2020Q2 us-gaap Lease Cost
LeaseCost
52845
us-gaap Lease Cost
LeaseCost
417005
us-gaap Lease Cost
LeaseCost
105198
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y5M1D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M13D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0592
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0767
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
548278
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1119081
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1046796
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
967663
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
847126
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1132870
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5661814
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
857274
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4804540
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
390787
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
13.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
157267
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
38.65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
42513
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
39.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
6735
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
11.70
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
498806
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.31
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
47332
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.03
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M18D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1325903
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13638
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
44.00
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
16972
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.71
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
43998
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.46
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M6D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
695500
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
20158
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y10M24D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
566037
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1193454
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100493
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2063529
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
225214
CY2020Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
240100
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.00
CY2021Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
0
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0
CY2020Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
110000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
268500
CY2021Q2 us-gaap Related Party Costs
RelatedPartyCosts
1950
CY2020Q2 us-gaap Related Party Costs
RelatedPartyCosts
15185
us-gaap Related Party Costs
RelatedPartyCosts
2730
us-gaap Related Party Costs
RelatedPartyCosts
27237
CY2021Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
84558
CY2020Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
42911
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
227681
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
91812
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2091434
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
160798
us-gaap Net Income Loss
NetIncomeLoss
-5491152
us-gaap Net Income Loss
NetIncomeLoss
118027
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14048136
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9996775
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13750775
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9996939
CY2020Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
29767
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
17889
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3483
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1441
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14048136
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10030025
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13750775
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10016269
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
9200000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
4500000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2600000
fthm Income Tax Expense Benefit Net
IncomeTaxExpenseBenefitNet
2600000
fthm Income Tax Expense Benefit Net
IncomeTaxExpenseBenefitNet
2000
CY2021Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3300000
CY2021Q2 fthm Pre Existing Deferred Tax Assets Realized
PreExistingDeferredTaxAssetsRealized
1600000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84182954
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38688744
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133828443
CY2021Q2 fthm Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
-2272971
CY2020Q2 fthm Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
329446
fthm Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
-4315283
fthm Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
464509
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
744451
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44496
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
846880
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63771
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
33658
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22659
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
88014
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-55497
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2614925
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2609925
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1193454
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
100493
us-gaap Share Based Compensation
ShareBasedCompensation
2063529
us-gaap Share Based Compensation
ShareBasedCompensation
225214
CY2021Q2 fthm Transaction Related Costs
TransactionRelatedCosts
529071
fthm Transaction Related Costs
TransactionRelatedCosts
963399
fthm Transaction Related Costs
TransactionRelatedCosts
0
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2091434
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
160798
us-gaap Net Income Loss
NetIncomeLoss
-5491152
us-gaap Net Income Loss
NetIncomeLoss
118027

Files In Submission

Name View Source Status
0001104659-21-104263-index-headers.html Edgar Link pending
0001104659-21-104263-index.html Edgar Link pending
0001104659-21-104263.txt Edgar Link pending
0001104659-21-104263-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fthm-20210630.xsd Edgar Link pending
fthm-20210630x10q.htm Edgar Link pending
fthm-20210630x10q_htm.xml Edgar Link completed
fthm-20210630xex31d1.htm Edgar Link pending
fthm-20210630xex31d2.htm Edgar Link pending
fthm-20210630xex32d1.htm Edgar Link pending
fthm-20210630_cal.xml Edgar Link unprocessable
fthm-20210630_def.xml Edgar Link unprocessable
fthm-20210630_lab.xml Edgar Link unprocessable
fthm-20210630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending